To recap, in part 1 we talked about Evolus (Nasdaq: EOLS), a relatively young company (no pun intended) entering the medical aesthetics market. Their first product Jeuveau was approved by FDA in … [Read more...] about Evolus: A Performance Beauty Company “Built to Grow Overnight”: Part 2
stocks
Global ESG Portfolios: Part 1
This summer I'm living in Japan, uniquely positioning me to observe some of the key metrics for ESGs through a global lens. This article will be part one of a multi part series covering ESG funds … [Read more...] about Global ESG Portfolios: Part 1
DVAX Restructuring Surprise; Was A Sell-Off The Right Reaction?
Sometimes during the lifetime of a company significant shifts in priorities and resource allocation are made. I believe the ability to recognize the need for such changes and the wherewithal to carry … [Read more...] about DVAX Restructuring Surprise; Was A Sell-Off The Right Reaction?
Investor Alert: Endra Life Scienes (NDRA)
Background Endra Life Sciences (NDRA) is a clinical stage medical device company we started following in April, 2019. The share price galloped up to a high near $3.30 in March in anticipation of … [Read more...] about Investor Alert: Endra Life Scienes (NDRA)
Is Zoom Really Worth $19 Billion?
In this article I will discuss the following Zooms valuation & Finances; is 19 billion fair? Competitive landscapeRisks to investorsOther current opportunities for … [Read more...] about Is Zoom Really Worth $19 Billion?
Biopharma Stock Watch May 6th-10th
Last Week Healthcare finally took a turn for the better. The XBI (S&P Biotech ETF) got off to a rough start declining 4 points but bounced back +3.86% by Friday's close. The IBB ( iShares … [Read more...] about Biopharma Stock Watch May 6th-10th
Investing In This Biotech Sector Could Triple Your Net Wealth In 3-Years
Some of the hottest stocks on the market are in the biotech sector. Of these, some of the hottest of the hot are in the NAFLD/NASH space. The reason being is the magnitude of disease prevalence and … [Read more...] about Investing In This Biotech Sector Could Triple Your Net Wealth In 3-Years
Should You Buy The ZOOM IPO?
Zoom has announced that it will be going public on April 18th 2019. This has generated substantial hype and lead to a valuation of $36 per share tomorrow. In this article I will discuss; Potential … [Read more...] about Should You Buy The ZOOM IPO?
An Intro to EMA’s When Trading Biotech Stocks
https://www.youtube.com/watch?v=4MecjQHamEo&ab_channel=M%26SMoneyMoves … [Read more...] about An Intro to EMA’s When Trading Biotech Stocks
MS Identified Its Next Swing
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Preface WOW. We are absolutely elated with the performance of our last swing move on SCYX. In case you missed it on … [Read more...] about MS Identified Its Next Swing